Efficacy and Safety of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants with Moderate-to-Severe Acne: The Patient Journey. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s494, 2024. DOI: 10.25251/skin.8.supp.494. Disponível em: https://skin.dermsquared.com/skin/article/view/3065. Acesso em: 11 jun. 2025.